UK markets close in 5 hours 52 minutes

Arbutus Biopharma Corporation (ABUS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.7200-0.0300 (-1.09%)
At close: 04:00PM EDT
2.7300 +0.01 (+0.37%)
After hours: 04:39PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
26,285
30,776
109,282
52,251
Other short-term investments
99,718
116,137
46,035
71,017
Total cash
126,003
146,913
155,317
123,268
Net receivables
1,776
1,352
899
1,312
Other current assets
4,248
2,874
4,445
-
Total current assets
132,027
151,139
160,661
127,704
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
17,990
17,615
17,449
16,953
Accumulated depreciation
-11,900
-10,801
-9,374
-7,621
Net property, plant and equipment
6,090
6,814
8,075
9,332
Equity and other investments
6,284
37,363
35,688
0
Other long-term assets
-
103
61
44
Total non-current assets
12,374
44,280
43,824
9,376
Total assets
144,401
195,419
204,485
137,080
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
3,223
3,520
3,174
2,994
Accrued liabilities
7,048
12,509
7,664
5,907
Deferred revenues
11,791
16,456
0
-
Other current liabilities
-
-
26
250
Total current liabilities
22,487
32,857
11,221
9,541
Non-current liabilities
Deferred revenues
0
5,999
0
-
Other long-term liabilities
14,553
17,896
21,594
22,980
Total non-current liabilities
15,896
25,710
23,825
25,573
Total liabilities
38,383
58,567
35,046
35,114
Stockholders' equity
Common stock
1,349,821
1,318,737
1,286,636
1,135,347
Retained earnings
-1,276,652
-1,203,803
-1,134,347
-1,045,961
Accumulated other comprehensive income
-48,421
-50,488
-48,335
-48,171
Total stockholders' equity
106,018
136,852
169,439
101,966
Total liabilities and stockholders' equity
144,401
195,419
204,485
137,080